1 Product identity
Ingredient risk
Contains a high-risk ingredient

Midlife Balance Formula

BrandEmeritaBotanical Tablet or Pill 12 ingredients 1 high-risk DSLD #26233
Net contents: 60 Gluten-Free Vegetarian Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-09-25
2 Ingredients (12)
IngredientGroupSafety
Red Clover ExtractRed CloverConditionally Safe
EleutheroEleuthero
DandelionDandelion
DandelionDandelion
AlfalfaAlfalfa
Black Cohosh extractBlack CohoshHigh risk
Chaste Tree berry extractChastetree
Calcium PhosphateCalciumConditionally Safe
Microcrystalline CelluloseCellulose
Croscarmellose SodiumCroscarmellose Sodium
Stearic AcidStearic Acid
Silicon DioxideSiliconGenerally Safe
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ High-risk ingredient — documented serious harm
Black Cohosh  🇺🇸 🇦🇺 🇪🇺 — Hepatotoxicity cases including liver failure — limit 6 months [1]
3 Safety cross-reference
Red Clover — Conditionally Safe
⚠ Estrogenic (isoflavones)
⚠ May increase bleeding risk
Black Cohosh — High risk
⚠ HEPATOTOXICITY (rare but serious)
⚠ Limit to 6 months
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID26233
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-09-25
6 More from Emerita
View Emerita Safety Scorecard → 3 products
Libido FormulaPro-Gest Balancing Cream - Lavender
7 Cite this page
Vancouver
Pkhakadze G. Midlife Balance Formula — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 25]. Available from: https://supplement.ge/products/midlife-balance-formula-26233/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG